pt of an audit opinion that contains a going concern qualification and does not reflect any change or amendment to the consolidated financial statements as filed. Further information regarding the going concern qualification is contained in AMDL's Annual Report on Form 10-K for the year ended December 31, 2008.
Conference Call
The Company will hold a conference call at 1:30 p.m. PDT on Monday, May 18, 2009 to discuss first quarter 2009 results. Listeners may access the call by dialing 1.888.490.1524 or 1.706.902.3245 for international callers, access code 10468976. A webcast will also be available through AMDL's website at www.amdl.com. A replay of the call will be available through May 20, 2009. For additional information on AMDL and its portfolio of products visit the Company's corporate website at www.amdl.com . For Investor Relations information contact Kristine Szarkowitz at kszarkowitz@amdl.com or 1.206.310.5323.
About AMDL
Headquartered in Tustin, CA with operations in China, AMDL, Inc., along with its subsidiary Jade Pharmaceutical Inc. (JPI), is a pharmaceutical company devoted to the research, development, manufacturing, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products. The Company employs over 510 people in the US and China.
Forward Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this document include certain predictions and projections that may be considered forward-looking statements under securities law. These statements involve a number of important risks and unc
'/>"/>
SOURCE AMDL, Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 Related medicine news :1.
AMDL, Inc. Selected as #1 Small-Cap Stock Pick for 20092.
Rudd Report Gives AMDL, Inc. a Strong Buy Recommendation in Year-End Financial Research Report3.
AMDL, Inc. Completes Revision of Performance & Equity Incentive Compensation Plan4.
AMDL, Inc. Chairman & CEO Announces Expert Opinion on Chinas Economic Forecast5.
AMDL, Inc. Announces Final Closing of Private Placement of Senior Notes6.
AMDL, Inc. Issues Correction to January 30, 2009 Press Release Announcing Closing of Private Placement of Senior Notes7.
AMDL, Inc. to Present at 5th Annual Winter Technology Conference Hosted by Security Research Associates, Inc.8.
AMDL, Inc. Reports 2008 Year End Financial Results and Fiscal Year 2009 Financial Targets9.
AMDL, Inc. Enters Into Distribution Agreements With GenWay Biotech, Inc. to Advance Commercialization of the DR-70 (FDP) Cancer Test in the US and Canada10.
HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness11.
CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael